Analysis of drugs in plasma samples from schizophrenic patients by column-switching liquid chromatography-tandem mass spectrometry with organic-inorganic hybrid cyanopropyl monolithic column

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 993-994, Issue , 2015, Pages 26-35

  Domingues, Diego Soares ^a   Souza, Israel Donizeti de ^a   Queiroz, Maria Eugênia Costa ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Column switching; Liquid chromatography tandem mass spectrometry; Organic inorganic hybrid monolith; Plasma samples; Schizophrenia

Indexed keywords

CHROMATOGRAPHY; DRUG PRODUCTS; ELECTROSPRAY IONIZATION; HIGH PRESSURE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETRY; PATIENT MONITORING; POSITIVE IONS; SPECTROMETRY; SWITCHING;

COLUMN SWITCHING; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; ORGANIC-INORGANIC HYBRID; PLASMA SAMPLES; SCHIZOPHRENIA;

COLUMN CHROMATOGRAPHY;

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CARBAMAZEPINE; CHLORPROMAZINE; CITALOPRAM; CLOMIPRAMINE; CLONAZEPAM; CLOZAPINE; DIAZEPAM; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; INORGANIC COMPOUND; LAMOTRIGINE; MIRTAZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; ORGANIC COMPOUND; ORGANIC INORGANIC HYBRID CYANOPROPYL MONOLITHIC COLUMN; PAROXETINE; QUETIAPINE; SERTRALINE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; DRUG DETERMINATION; DRUG MONITORING; DRUG TARGETING; ELECTROSPRAY; HUMAN; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MENTAL PATIENT; PRIORITY JOURNAL; SCHIZOPHRENIA; TANDEM MASS SPECTROMETRY; BLOOD; DEVICES; EVALUATION STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF DETECTION; PROCEDURES;

ANTI-ANXIETY AGENTS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; LIMIT OF DETECTION; SCHIZOPHRENIA; TANDEM MASS SPECTROMETRY;

EID: 84929308724     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2015.04.040     Document Type: Article

References (46)

1. Addington J., Cadenhead K.S., Cannon T.D., Cornblatt B., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M., Walker E.F., Woods S.W., Heinssen R. North American Prodrome Longitudinal Study: A collaborative multisite approach to prodromal schizophrenia research. Schizophr. Bull. 2007, 33:665-672.
2. Asor E., Ben-Shachar D. Platelets A possible glance into brain biological processes in schizophrenia. World J. Psychiatry. 2012, 2:124-133.
3. Reeder C., Smedley N., Butt K., Bogner D., Wykes T. Cognitive predictors of social functioning improvements following cognitive remediation for schizophrenia. Schizophr. Bull. 2006, 32(Suppl. 1):123-131.
4. Leucht S., Barnes T.R., Kissling W., Engel R.R., Correll C., Kane J.M. Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized controlled trials. Am. J. Psychiatry 2003, 160:1209-1222.
5. Correll C.U. Real-life switching strategies with second-generation antipsychotics. J. Clin. Psychiat. 2006, 67:160-161.
6. Tsutsumi C., Uchida H., Suzuki T., Watanabe K., Takeuchi H., Nakajima S., Kimura Y., Tsutsumi Y., Ishii K., Imasaka Y., Kapur S. The evolution of antipsychotic switch and polypharmacy in natural practice - A longitudinal perspective. Schizophr. Res. 2011, 130:40-46.
7. Šagud M., Vuksan-Ćusa B., Živković M., Vlatković S., Kramarić M., Bradaš Z., Mihaljević-Peleš A. Antipsychotics: to combine or not to combine?. Psychiatr. Danubina. 2013, 25:306-310.
8. Buchanan R.W., Javitt D.C., Marder S.R., Schooler N.R., Gold J.M., McMahon R.P., Heresco-Levy U., Carpenter W.T. The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments. Am. J. Psychiatry 2007, 164:1593-1602.
9. Kataoka H., Saito K. Recent advances in column switching sample preparation in bioanalysis. Bioanalysis 2012, 4:809-832.
10. Jayamanne M., Granelli I., Tjernberg A., Edlund P.O. Development of a two-dimensional liquid chromatography system for isolation of drug metabolites. J. Pharm. Biomed. Anal. 2010, 51:649-657.
11. Eckert E., Goen T. Rapid determination of four short-chain alkyl mercapturic acids in human urine by column-switching liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 2014, 965:54-60.
12. Fagundes V.F., Leite C.P., Pianetti G.A., Fernandes C. Rapid and direct analysis of statins in human plasma by column-switching liquid chromatography with restricted-access material. J. Chromatogr. B 2014, 947-948:8-16.
13. Park M., Kim J., Park Y., In S., Kim E., Park Y. Quantitative determination of 11-nor-9-carboxy-tetrahydrocannabinol in hair by column switching LC-ESI-MS(3). J. Chromatogr. B 2014, 947-948:179-185.
14. Xiong X., Yang Z., Li Y., Xiao L., Jiang L., Chen Y., Ma M., Chen B. Preparation of a polyhedral oligomeric silsesquioxane-based perfluorinated monolithic column. J. Chromatogr. A 2013, 1304:85-91.
15. Svec F. Stellan Hjerten's contribution to the development of monolithic stationary phases. Electrophoresis 2008, 29:1593-1603.
16. Ou J., Liu Z., Wang H., Lin H., Dong J., Zou H. Recent development of hybrid organic-silica monolithic columns in CEC and capillary LC. Electrophoresis 2014, 00:1-14.
17. Tran L.N., Dixit S., Park J.H. Enantioseparation of basic chiral compounds on a clindamycin phosphate-silica/zirconia hybrid monolith by capillary electrochromatography. J. Chromatogr. A 2014, 1356:289-293.
18. Wu M., Wu R., Zhang Z., Zou H. Preparation and application of organic-silica hybrid monolithic capillary columns. Electrophoresis 2011, 32:105-115.
19. Liu X.F., Sun N., Zhu Q.F., Wu M., Ye Y., Chen H.X. Preparation, characterization and application of organic-inorganic hybrid caffeine imprinted monolith. J. Chromatogr. A 2013, 1304:10-17.
20. Brothier F., Pichon V. Miniaturized DNA aptamer-based monolithic sorbent for selective extraction of a target analyte coupled on-line to nanoLC. Anal. Bioanal. Chem. 2014, 406:7875-7886.
21. Lee D.Y., Bowen B.P., Northen T.R. Mass spectrometry-based metabolomics, analysis of metabolite-protein interactions, and imaging. Biotechniques 2010, 49:557-565.
22. Yang H.H., Chen Y.Z., Liu Y.X., Nie L.H., Yao S.Z. One-pot synthesis of (3-sulfopropyl methacrylate potassium)-silica hybrid monolith via thiol-ene click chemistry for CEC. Electrophoresis 2013, 34:510-517.
23. Ortiz-Villanueva E., Benavente F., Gimenez E., Yilmaz F., Sanz-Nebot V. Preparation and evaluation of open tubular C18-silica monolithic microcartridges for preconcentration of peptides by on-line solid phase extraction capillary electrophoresis. Anal. Chim. Acta 2014, 846:51-59.
24. Zhang Y., Liu H.Y., Zhang X.Y., Lei H., Bai L.G., Yang G.L. On-line solid phase extraction using organic-inorganic hybrid monolithic columns for the determination of trace beta-lactam antibiotics in milk and water samples. Talanta 2013, 104:17-21.
25. Gilart N., Marce R.M., Cormack P.A., Fontanals N., Borrull F. Development of new polar monolithic coatings for stir bar sorptive extraction. J. Sep. Sci. 2014, 37:2225-2232.
26. Mei M., Huang X., Yuan D. Multiple monolithic fiber solid-phase microextraction: a new extraction approach for aqueous samples. J. Chromatogr. A 2014, 1345:29-36.
27. Liu X.F., Zhu Q.F., Chen H.X., Zhou L.Z., Dang X.P., Huang J.L. Preparation of 2,4-dichlorophenoxyacetic acid imprinted organic-inorganic hybrid monolithic column and application to selective solid-phase microextraction. J. Chromatogr. B 2014, 951:32-37.
28. Zheng M.M., Ruan G.D., Feng Y.Q. Hybrid organic-inorganic silica monolith with hydrophobic/strong cation-exchange functional groups as a sorbent for micro-solid phase extraction. J. Chromatogr. A 2009, 1216:7739-7746.
29. Zheng M.M., Wang S.T., Hu W.K., Feng Y.Q. In-tube solid-phase microextraction based on hybrid silica monolith coupled to liquid chromatography-mass spectrometry for automated analysis of ten antidepressants in human urine and plasma. J. Chromatogr. A 2010, 1217:7493-7501.
30. Schaefer A., Piquard F., Haberey P. Plasma amino acids analysis - effects of delayed samples preparation and of storage. Clin. Chim. Acta 1987, 164:163-169.
31. Sahai S., Uhlhaas S. Stability of amino acids in human plasma. Clin. Chim. Acta 1985, 148:255-259.
32. Breier M., Wahl S., Prehn C., Fugmann M., Ferrari U., Weise M., Banning F., Seissler J., Grallert H., Adamski J., Lechner A. Targeted metabolomics identifies reliable and stable metabolites in human serum and plasma samples. Plos One 2014, 9:e89728.
33. Gonzalez O., Blanco M.E., Iriarte G., Bartolome L., Maguregui M.I., Alonso R.M. Bioanalytical chromatographic method validation according to current regulations, with a special focus on the non-well defined parameters limit of quantification, robustness and matrix effect. J. Chromatogr. A 2014, 1353:10-27.
34. Zhang G., Terry A.V.Jr., Bartlett M.G. Simultaneous determination of five antipsychotic drugs in rat plasma by high performance liquid chromatography with ultraviolet detection. J. Chromatogr. B 2007, 856:20-28.
35. Bhatt J., Subbaiah G., Singh S. Liquid chromatography/tandem mass spectrometry method for simultaneous determination of risperidone and its active metabolite 9-hydroxyrisperidone in human plasma. Rapid Commun. Mass Spectrom. 2006, 20:2109-2114.
36. Li W., Fries D.P., Malik A. Sol-gel stationary phases for capillary electrochromatography. J. Chromatogr. A 2004, 1044:23-52.
37. Xu L., Lee H.K. Preparation, characterization and analytical application of a hybrid organic-inorganic silica-based monolith. J. Chromatogr. A 2008, 1195:78-84.
38. McKean A., Vella-Brincat J., Begg E. Prescribing and monitoring clozapine in christchurch. Australas Psychiatry. 2008, 16:263-267.
39. Matkó S., Toldy A., Keszei S., Anna P., Bertalan G., Marosi G. Flame retardancy of biodegradable polymers and biocomposites. Polym. Degrad. Stab. 2005, 88:138-145.
40. Innocenzi P. Infrared spectroscopy of sol-gel derived silica-based films: a spectra-microstructure overview. J. Non-Crystalline Solids 2003, 316:309-319.
41. Al-Oweini R., El-Rassy H. Synthesis and characterization by FTIR spectroscopy of silica aerogels prepared using several Si(OR)4 and R''Si(OR')3 precursors. J. Mol. Struct. 2009, 919:140-145.
42. Wahab M. Hybrid periodic mesoporous organosilica materials prepared from 1 2-bis(triethoxysilyl)ethane and (3-cyanopropyl)triethoxysilane. Micropor. Mesopor. Mater. 2004, 69:19-27.
43. Silva B.J.G., Lancas F.M., Queiroz M.E.C. In-tube solid-phase microextraction coupled to liquid chromatography (in-tube SPME/LC) analysis of nontricyclic antidepressants in human plasma. J. Chromatogr. B 2008, 862:181-188.
44. Ma Q., Chen M., Shi Z.G., Feng Y.Q. Preparation of a poly(N-isopropylacrylamide-co-ethylene dimethacrylate) monolithic capillary and its application for in-tube solid-phase microextraction coupled to high-performance liquid chromatography. J. Sep. Sci. 2009, 32:2592-2600.
45. Silva B.J.G., Lancas F.M., Queiroz M.E.C. Determination of fluoxetine and norfluoxetine enantiomers in human plasma by polypyrrole-coated capillary in-tube solid-phase microextraction coupled with liquid chromatography-fluorescence detection. J. Chromatogr. A 2009, 1216:8590-8597.
46. Hiemke C., Baumann P., Bergemann N., Conca A., Dietmaier O., Egberts K., Fric M., Gerlach M., Greiner C., Grunder G., Haen E., Havemann-Reinecke U., Sirot E.J., Kirchherr H., Laux G., Lutz U.C., Messer T., Muller M.J., Pfuhlmann B., Rambeck B., Riederer P., Schoppek B., Stingl J., Uhr M., Ulrich S., Waschgler R., Zernig G. AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011. Pharmacopsychiatry 2011, 44:195-235.